In a welcome move, Sabra Healthcare REIT saw its Relative Strength Rating improve from 68 to 74 on Wednesday.
Can You Really Time The Stock Market?
IBD's proprietary rating tracks share price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research reveals that the best stocks typically have an RS Rating of at least 80 as they launch their largest price moves. See if Sabra Healthcare REIT can continue to rebound and hit that benchmark.
Sabra Healthcare REIT is working on a saucer without handle with a 20.03 buy point. See if the stock can clear the breakout price in volume at least 40% above average.
The company reported 6% EPS growth in its most recent report. Sales gains came in at 10%.
The company earns the No. 7 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT, Farmland Partners and Postal Realty Trust Cl A are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
